These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia. Marfaing-Koka A; Wolf M; Boyer-Neumann C; Meyer D; Odievre M; Labrune P J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):566-70. PubMed ID: 14581798 [TBL] [Abstract][Full Text] [Related]
26. Rapid screening of 12 common mutations in Turkish GSD 1a patients using electronic DNA microarray. Eminoglu TF; Ezgu FS; Hasanoglu A; Tumer L Gene; 2013 Apr; 518(2):346-50. PubMed ID: 23352793 [TBL] [Abstract][Full Text] [Related]
27. Liver histology in children with glycogen storage disorders type VI and IX. Degrassi I; Deheragoda M; Creegen D; Mundy H; Mustafa A; Vara R; Hadzic N Dig Liver Dis; 2021 Jan; 53(1):86-93. PubMed ID: 32505569 [TBL] [Abstract][Full Text] [Related]
28. Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors. Beaty RM; Jackson M; Peterson D; Bird A; Brown T; Benjamin DK; Juopperi T; Kishnani P; Boney A; Chen YT; Koeberl DD Gene Ther; 2002 Aug; 9(15):1015-22. PubMed ID: 12101432 [TBL] [Abstract][Full Text] [Related]
29. Hepatic ultrasound findings in the glycogen storage diseases. Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397 [TBL] [Abstract][Full Text] [Related]
30. The prenatal determination of glucose-6-phosphatase activity by fetal liver biopsy. Golbus MS; Simpson TJ; Koresawa M; Appelman Z; Alpers CE Prenat Diagn; 1988 Jul; 8(6):401-4. PubMed ID: 2850549 [TBL] [Abstract][Full Text] [Related]
31. Hepatocyte transplantation for glycogen storage disease type Ib. Lee KW; Lee JH; Shin SW; Kim SJ; Joh JW; Lee DH; Kim JW; Park HY; Lee SY; Lee HH; Park JW; Kim SY; Yoon HH; Jung DH; Choe YH; Lee SK Cell Transplant; 2007; 16(6):629-37. PubMed ID: 17912954 [TBL] [Abstract][Full Text] [Related]
32. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? Demo E; Frush D; Gottfried M; Koepke J; Boney A; Bali D; Chen YT; Kishnani PS J Hepatol; 2007 Mar; 46(3):492-8. PubMed ID: 17196294 [TBL] [Abstract][Full Text] [Related]
33. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. Geberhiwot T; Alger S; McKiernan P; Packard C; Caslake M; Elias E; Cramb R J Inherit Metab Dis; 2007 Jun; 30(3):406. PubMed ID: 17407002 [TBL] [Abstract][Full Text] [Related]
34. Homogénéité mutationnelle de la glycogénose de type Ia en Tunisie. Cherif W; Rhouma FB; Chehida AB; Azzouz H; Monastiri K; Amri F; Chemli J; Kaabachi N; Abdelhak S; Tebib N; Dridi MF Pathol Biol (Paris); 2011 Aug; 59(4):e93-6. PubMed ID: 19896294 [TBL] [Abstract][Full Text] [Related]
36. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Manzia TM; Angelico R; Toti L; Cillis A; Ciano P; Orlando G; Anselmo A; Angelico M; Tisone G Transplant Proc; 2011 May; 43(4):1181-3. PubMed ID: 21620082 [TBL] [Abstract][Full Text] [Related]
37. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Kishnani PS; Chuang TP; Bali D; Koeberl D; Austin S; Weinstein DA; Murphy E; Chen YT; Boyette K; Liu CH; Chen YT; Li LH Hum Mol Genet; 2009 Dec; 18(24):4781-90. PubMed ID: 19762333 [TBL] [Abstract][Full Text] [Related]
38. Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart. Rake JP; ten Berge AM; Visser G; Verlind E; Niezen-Koning KE; Buys CH; Smit GP; Scheffer H Eur J Pediatr; 2000 May; 159(5):322-30. PubMed ID: 10834516 [TBL] [Abstract][Full Text] [Related]
39. Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer. Ghosh A; Allamarvdasht M; Pan CJ; Sun MS; Mansfield BC; Byrne BJ; Chou JY Gene Ther; 2006 Feb; 13(4):321-9. PubMed ID: 16195703 [TBL] [Abstract][Full Text] [Related]
40. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control. Peeks F; Steunenberg TAH; de Boer F; Rubio-Gozalbo ME; Williams M; Burghard R; Rajas F; Oosterveer MH; Weinstein DA; Derks TGJ J Inherit Metab Dis; 2017 Sep; 40(5):695-702. PubMed ID: 28397058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]